103 related articles for article (PubMed ID: 6192289)
1. Surgery in patients with advanced germ cell malignancy following a clinical partial response to chemotherapy.
Reddel RR; Thompson JF; Raghavan D; Tattersall MH; Levi JA; Coupland GA; Fox RM; Coates AS; Woods RL; Ng AB
J Surg Oncol; 1983 Aug; 23(4):223-7. PubMed ID: 6192289
[TBL] [Abstract][Full Text] [Related]
2. Postchemotherapy surgery in nonseminomatous testicular tumors.
Hornák M; Ondrus D; Matoska J; Cársky S
Eur Urol; 1996; 29(3):325-30. PubMed ID: 8740018
[TBL] [Abstract][Full Text] [Related]
3. Surgical resection of solitary metastases after chemotherapy in patients with nonseminomatous germ cell tumors and elevated serum tumor markers.
Wood DP; Herr HW; Motzer RJ; Reuter V; Sogani PC; Morse MJ; Bosl GJ
Cancer; 1992 Nov; 70(9):2354-7. PubMed ID: 1382832
[TBL] [Abstract][Full Text] [Related]
4. Early resection of residual tumor during cisplatin, vinblastine, bleomycin combination chemotherapy in stage III and bulky stage II nonseminomatous testicular cancer.
Pizzocaro G; Salvioni R; Pasi M; Zanoni F; Milani A; Pilotti S; Monfardini S
Cancer; 1985 Jul; 56(2):249-55. PubMed ID: 2408728
[TBL] [Abstract][Full Text] [Related]
5. Elevated serum tumor markers in patients with testicular cancer after induction chemotherapy due to a reservoir of markers in cystic differentiated mature teratoma.
van der Gaast A; Hoekstra JW; Croles JJ; Splinter TA
J Urol; 1991 Apr; 145(4):829-31. PubMed ID: 1706441
[TBL] [Abstract][Full Text] [Related]
6. The extent of surgery after chemotherapy for advanced germ cell tumors.
Freiha FS; Shortliffe LD; Rouse RV; Mark JB; Hannigan JF; Aston D; Spaulding JT; Williams RD; Torti FM
J Urol; 1984 Nov; 132(5):915-7. PubMed ID: 6208386
[TBL] [Abstract][Full Text] [Related]
7. Cisplatin, etoposide, bleomycin first-line therapy and early resection of residual tumor in far-advanced germinal testis cancer.
Pizzocaro G; Piva L; Salvioni R; Zanoni F; Milani A
Cancer; 1985 Nov; 56(10):2411-5. PubMed ID: 2412683
[TBL] [Abstract][Full Text] [Related]
8. [Improved prognosis of intracranial germ cell tumors by intensified therapy: results of the MAKEI 89 therapy protocol].
Göbel U; Bamberg M; Calaminus G; Gnekow AK; Herrmann HD; Lenard HG; Spaar HJ; Niethammer D; Kühl J; Harms D
Klin Padiatr; 1993; 205(4):217-24. PubMed ID: 7690863
[TBL] [Abstract][Full Text] [Related]
9. VAB-5 combination chemotherapy in prognostically poor risk patients with germ cell tumors.
Vugrin D; Whitmore WF; Golbey RB
Cancer; 1983 Mar; 51(6):1072-5. PubMed ID: 6185211
[TBL] [Abstract][Full Text] [Related]
10. Predictive factors for the histologic nature of residual tumor mass after chemotherapy in patients with advanced testicular cancer.
Matsuyama H; Yamamoto N; Sakatoku J; Suga A; Hayashida S; Kamiryo Y; Nagata K; Naito K
Urology; 1994 Sep; 44(3):392-8; discussion 398-9. PubMed ID: 8073552
[TBL] [Abstract][Full Text] [Related]
11. Outcome of patients with residual germ cell or non-germ cell malignancy after resection of primary mediastinal nonseminomatous germ cell cancer.
Schneider BP; Kesler KA; Brooks JA; Yiannoutsos C; Einhorn LH
J Clin Oncol; 2004 Apr; 22(7):1195-200. PubMed ID: 15051766
[TBL] [Abstract][Full Text] [Related]
12. Reassessment of the role of adjunctive surgical therapy in the treatment of advanced germ cell tumors.
Carter GE; Lieskovsky G; Skinner DG; Daniels JR
J Urol; 1987 Dec; 138(6):1397-401. PubMed ID: 2446018
[TBL] [Abstract][Full Text] [Related]
13. Vinblastine, bleomycin, and cisplatin in malignant germ cell tumors of the ovary.
Taylor MH; Depetrillo AD; Turner AR
Cancer; 1985 Sep; 56(6):1341-9. PubMed ID: 2411377
[TBL] [Abstract][Full Text] [Related]
14. A prospective study of cisplatin-based combination chemotherapy in advanced germ cell malignancy: role of maintenance and long-term follow-up.
Levi JA; Thomson D; Sandeman T; Tattersall M; Raghavan D; Byrne M; Gill G; Harvey V; Burns I; Snyder R
J Clin Oncol; 1988 Jul; 6(7):1154-60. PubMed ID: 2455778
[TBL] [Abstract][Full Text] [Related]
15. High complete response rate in children with advanced germ cell tumors using cisplatin-containing combination chemotherapy.
Pinkerton CR; Pritchard J; Spitz L
J Clin Oncol; 1986 Feb; 4(2):194-9. PubMed ID: 2418168
[TBL] [Abstract][Full Text] [Related]
16. [Five cases of primary intracranial germ cell tumor treated by combination chemotherapy with cisplatin].
Miyamachi K; Aida T; Abe H
No Shinkei Geka; 1988 Aug; 16(9):1053-8. PubMed ID: 2462694
[TBL] [Abstract][Full Text] [Related]
17. Vinblastine, actinomycin D, bleomycin, cyclophosphamide and cis-platinum combination chemotherapy in metastatic testis cancer--a 1-year program.
Vugrin D; Whitmore WF; Golbey RB
J Urol; 1982 Dec; 128(6):1205-8. PubMed ID: 6185697
[TBL] [Abstract][Full Text] [Related]
18. Sequential excision of residual thoracic and retroperitoneal masses after chemotherapy for stage III germ cell tumors.
Tiffany P; Morse MJ; Bosl G; Vaughan ED; Sogani PC; Herr HW; Whitmore WF
Cancer; 1986 Mar; 57(5):978-83. PubMed ID: 3002596
[TBL] [Abstract][Full Text] [Related]
19. [Postchemotherapy residual tumour resection in complex metastatic sites of advanced testicular germ cell tumours].
Paffenholz P; Pfister D; Heidenreich A
Urologe A; 2016 May; 55(5):632-40. PubMed ID: 26820659
[TBL] [Abstract][Full Text] [Related]
20. Teratoma following cisplatin-based combination chemotherapy for nonseminomatous germ cell tumors: a clinicopathological correlation.
Loehrer PJ; Hui S; Clark S; Seal M; Einhorn LH; Williams SD; Ulbright T; Mandelbaum I; Rowland R; Donohue JP
J Urol; 1986 Jun; 135(6):1183-9. PubMed ID: 2423708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
